Elite Pharmaceuticals Inc (ELTP) - Financial and Strategic SWOT Analysis Review
October 2019
46
About the Report
About the Report
Elite Pharmaceuticals Inc (ELTP)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Elite Pharmaceuticals Inc (Elite) is a specialty pharmaceutical company focuses on the development of oral sustained and controlled release drug products. The company manufactures and develops generic drugs upon marketing approvals via Abbreviated New Drug Applications (ANDA) and branded drugs via New Drug Application (NDA) for the treatment of pain, obesity, hypertension, depression, infection and allergy, among others. Elite also has a pipeline of abuse-deterrent opioids for the treatment of chronic pain. The company uses its proprietary ART (abuse-deterrent technology) platform to develop and manufacture oral, controlled-release drugs. Elite is headquartered in Northvale, New Jersey, the US.
Elite Pharmaceuticals Inc Key Recent Developments
Feb 11,2019: Elite pharmaceuticals reports financial results for the third quarter of fiscal year 2019 ended December 31, 2018 and provides conference call information
Nov 09,2018: Elite Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2019 Ended September 30, 2018 and Provides Conference Call Information
Oct 24,2018: Elite Pharmaceuticals reports positive results from a pivotal bioequivalence study
Aug 09,2018: Elite Pharmaceuticals reports financial results for the first quarter of fiscal year 2019 ended June 30, 2018
Aug 07,2018: Elite Pharmaceuticals appoints Aqeel A. Fatmi to its Board of Directors
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Elite Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Companies
Endo Pharmaceuticals Inc
Purdue Pharma LP
Mylan Laboratories Ltd
Collegium Pharmaceutical Inc
Sandoz Inc
Acura Pharmaceuticals Inc
Mallinckrodt LLC
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1-About the Company
Elite Pharmaceuticals Inc-Key Facts
Elite Pharmaceuticals Inc-Key Employees
Elite Pharmaceuticals Inc-Key Employee Biographies
Elite Pharmaceuticals Inc-Major Products and Services
Elite Pharmaceuticals Inc-History
Elite Pharmaceuticals Inc-Company Statement
Elite Pharmaceuticals Inc-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2-Company Analysis
Company Overview
Elite Pharmaceuticals Inc-Business Description
Business Segment: Branded Pharmaceuticals (NDA segment)
Overview
Performance
Business Segment: Generic Pharmaceuticals (ANDA segment)
Overview
Performance
Elite Pharmaceuticals Inc-Corporate Strategy
Elite Pharmaceuticals Inc-SWOT Analysis
SWOT Analysis-Overview
Elite Pharmaceuticals Inc-Strengths
Elite Pharmaceuticals Inc-Weaknesses
Elite Pharmaceuticals Inc-Opportunities
Elite Pharmaceuticals Inc-Threats
Elite Pharmaceuticals Inc-Key Competitors
Section 3-Company Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Performance Chart
Financial Performance
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Section 4-Company's Lifesciences Financial Deals and Alliances
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Elite Pharmaceuticals Inc, Recent Deals Summary
Section 5-Company's Recent Developments
Feb 11, 2019: Elite pharmaceuticals reports financial results for the third quarter of fiscal year 2019 ended December 31, 2018 and provides conference call information
Nov 09, 2018: Elite Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2019 Ended September 30, 2018 and Provides Conference Call Information
Oct 24, 2018: Elite Pharmaceuticals reports positive results from a pivotal bioequivalence study
Aug 09, 2018: Elite Pharmaceuticals reports financial results for the first quarter of fiscal year 2019 ended June 30, 2018
Aug 07, 2018: Elite Pharmaceuticals appoints Aqeel A. Fatmi to its Board of Directors
Jun 14, 2018: Elite Pharmaceuticals Announces Financial Results for the Fiscal Year Ended March 31, 2018
Feb 09, 2018: Elite Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2018 Ended December 31, 2017
Jan 10, 2018: Elite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release Generic
Section 6-Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Elite Pharmaceuticals Inc, Performance Chart (2015-2019)
Elite Pharmaceuticals Inc, Ratio Charts
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
List of Table
List of Tables
Elite Pharmaceuticals Inc, Key Facts
Elite Pharmaceuticals Inc, Key Employees
Elite Pharmaceuticals Inc, Key Employee Biographies
Elite Pharmaceuticals Inc, Major Products and Services
Elite Pharmaceuticals Inc, History
Elite Pharmaceuticals Inc, Subsidiaries
Elite Pharmaceuticals Inc, Key Competitors
Elite Pharmaceuticals Inc, Ratios based on current share price
Elite Pharmaceuticals Inc, Annual Ratios
Elite Pharmaceuticals Inc, Annual Ratios (Cont...1)
Elite Pharmaceuticals Inc, Interim Ratios
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Elite Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.